Cross Shawn
Chief Financial Officer · 15 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | Sale | 12,941 | $25.16 | $325,595.56 | filing |
| 2026-04-23 | PCRX | Pacira BioSciences, Inc. | Option exercise | 12,941 | $16.45 | $212,879.45 | filing |
| 2026-04-22 | PCRX | Pacira BioSciences, Inc. | Sale | 1,500 | $25.01 | $37,515.00 | filing |
| 2026-04-22 | PCRX | Pacira BioSciences, Inc. | Option exercise | 1,500 | $16.45 | $24,675.00 | filing |
| 2026-04-21 | PCRX | Pacira BioSciences, Inc. | Sale | 2,845 | $25.01 | $71,153.45 | filing |
| 2026-04-21 | PCRX | Pacira BioSciences, Inc. | Option exercise | 2,845 | $16.45 | $46,800.25 | filing |
| 2026-04-20 | PCRX | Pacira BioSciences, Inc. | Sale | 7,714 | $25.14 | $193,929.96 | filing |
| 2026-04-20 | PCRX | Pacira BioSciences, Inc. | Option exercise | 7,714 | $16.45 | $126,895.30 | filing |
| 2026-02-11 | PCRX | Pacira BioSciences, Inc. | Award | 49,091 | $0.00 | $0.00 | filing |
| 2025-12-10 | PCRX | Pacira BioSciences, Inc. | Sale | 9,104 | $25.14 | $228,874.56 | filing |
| 2025-12-10 | PCRX | Pacira BioSciences, Inc. | Option exercise | 9,104 | $16.45 | $149,760.80 | filing |
| 2025-12-09 | PCRX | Pacira BioSciences, Inc. | Sale | 15,896 | $25.03 | $397,876.88 | filing |
| 2025-12-09 | PCRX | Pacira BioSciences, Inc. | Option exercise | 15,896 | $16.45 | $261,489.20 | filing |
| 2025-11-10 | PCRX | Pacira BioSciences, Inc. | Sale | 12,060 | $22.09 | $266,405.40 | filing |
| 2025-10-31 | PCRX | Pacira BioSciences, Inc. | Tax withholding | 6,690 | $21.38 | $143,032.20 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.